Coronary artery aneurysms (CAAs) are uncommon and describe a localized dilatation of a
coronary artery segment more than 1.5-fold compared with adjacent normal segments. The …

The cellular and molecular processes that control vascular injury responses after
percutaneous coronary intervention involve a complex interplay among vascular cells and …

In 2008, the Guidelines for diagnosis and treatment of patients with vasospastic angina
(coronary spastic angina) 1 were developed by the Japanese Circulation Society, and the …

Background Absorbable scaffolds were designed to overcome the limitations of
conventional, non-absorbable metal-based drug-eluting stents. So far, only polymeric …

Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary
Spastic Angina) (JCS 2013) Toggle navigation J-STAGE home 資料・記事を探す 資料を探す:資料 …

Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

Background Coronary stents improve immediate and late results of balloon angioplasty by
tacking up dissections and preventing wall recoil. These goals are achieved within weeks …

Background Drug-eluting metallic coronary stents predispose to late stent thrombosis,
prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair …

Deployment of drug-eluting stents instead of bare-metal stents has dramatically reduced
restenosis rates, but rates of very late stent thrombosis (> 1 year postimplantation) have …

Gruntzig in 1977 was a huge leap forward in cardiovascular medicine and undoubtedly will
always be remembered as a revolution in the field of revascularization. However, this …